{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T08:53:57Z","timestamp":1776329637471,"version":"3.50.1"},"reference-count":10,"publisher":"Baskent University","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.6002\/ect.2020.0278","type":"journal-issue","created":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T06:42:28Z","timestamp":1623048148000},"source":"Crossref","is-referenced-by-count":1,"title":[],"prefix":"10.6002","volume":"23","member":"4021","reference":[{"key":"ref0","unstructured":"1. Anghel D, Tanasescu R, Campeanu A, Lupescu I, Podda G, Bajenaru O. Neurotoxicity of immunosuppressive therapies in organ transplantation. Maedica (Bucur). 2013;8(2):170-175"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Zivkovic SA, Abdel-Hamid H. Neurologic manifestations of transplant complications. Neurol Clin. 2010;28(1):235-251. doi:10.1016\/j.ncl.2009.09.011","DOI":"10.1016\/j.ncl.2009.09.011"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Zivkovic S. Neuroimaging and neurologic complications after organ transplantation. J Neuroimaging. 2007;17(2):110-123. doi:10.1111\/j.1552-6569.2007.00097.x","DOI":"10.1111\/j.1552-6569.2007.00097.x"},{"key":"ref3","unstructured":"4. Hardinger K, Magee CC. Pharmacology of cyclosporine and tacrolimus. In: Furst DE, Brennan DC, Lam AQ ,eds. UpToDate. Waltham, MA; 2019."},{"key":"ref4","unstructured":"5. Eidelman BH, Abu-Elmagd K, Wilson J, et al. Neurologic complications of FK 506. Transplant Proc. 1991;23(6):3175-3178"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Prommer E. Calcineurin-inhibitor pain syndrome. Clin J Pain. 2012;28(6):556-559. doi:10.1097\/AJP.0b013e31823a67f1","DOI":"10.1097\/AJP.0b013e31823a67f1"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Wijdicks EF, Wiesner RH, Krom RA. Neurotoxicity in liver transplant recipients with cyclosporine immunosuppression. Neurology. 1995;45(11):1962-1964. doi:10.1212\/wnl.45.11.1962","DOI":"10.1212\/WNL.45.11.1962"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Malvezzi P, Rostaing L. The safety of calcineurin inhibitors for kidney-transplant patients. Expert Opin Drug Saf. 2015;14(10):1531-1546. doi:10.1517\/14740338.2015.1083974","DOI":"10.1517\/14740338.2015.1083974"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Bican Demir A, Erer Ozbek S, Bora I, Hakyemez B, Tirnova I, Kaya E. Two cases with developing neurologic complications after liver transplant. Exp Clin Transplant. 2016;14(6):685-687. doi:10.6002\/ect.2014.0204","DOI":"10.6002\/ect.2014.0204"},{"key":"ref9","unstructured":"10. Cox J, Russo A. A case report on the delayed diagnosis of transverse myelitis in a 61-year-old male farmer. J Can Chiropr Assoc. 2020;64(2):131-138"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T03:09:23Z","timestamp":1751512163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/archive\/2025\/23\/6\/0\/442\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.2020.0278","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}